PTC Therapeutics, Inc.
- Last sale
- Nov 12, 2026 · -2.36%
- Market cap
- $5.29B
- 83.54M shares
- Filings
- 1,070
Q3 2026+114.5% FY25 yoy
Q3 2026N/M FY25 yoy
Q3 2026N/M FY25 yoy
Q3 2026derivedN/M FY25 yoy
Q3 2026N/M FY25 yoy
Q3 2026+26.3% FY25 yoy
- $5.29B
- —
- 4.6×
- —
- 0.04%
- —
Twelve months to Sep 30, 2026 · derived
Price
Nov 12, 2026 · IEX last sale
IEX last saleClose of recordAs traded
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
Financials
Revenue
| Period | Ended | Value | Kind | Source trail |
|---|---|---|---|---|
| FY 2025 | 2025-12-31 | $1,730,655,000 | reported | |
| FY 2024 | 2024-12-31 | $806,780,000 | reported | |
| FY 2023 | 2023-12-31 | $937,822,000 | reported | |
| FY 2022 | 2022-12-31 | $698,801,000 | reported | |
| FY 2021 | 2021-12-31 | $538,593,000 | reported | |
| FY 2020 | 2020-12-31 | $380,766,000 | reported | |
| FY 2019 | 2019-12-31 | $306,980,000 | reported | |
| FY 2018 | 2018-12-31 | $264,734,000 | reported | |
| FY 2017 | 2017-12-31 | $194,392,000 | reported | |
| FY 2016 | 2016-12-31 | $82,705,000 | reported | |
| FY 2015 | 2015-12-31 | $36,766,000 | reported | |
| FY 2014 | 2014-12-31 | $25,245,000 | reported |
Segments
LineFY2025ShareChange
United States$252.19M15%+21.7%
Non-US$235.89M14%−40.1%
All other countries$168.41M9.7%−14.7%
Russia$100.45M5.8%−4.7%
Brazil$65.66M3.8%−8.9%
Total$1.73B
Pharmaceutical preparations
PTC Therapeutics, Inc. is the 28th largest of the 553 covered companies the SEC files under this code, by revenue. SIC 2834
CompanyRevenueGrowthNet marginMarket cap
RPRXRoyalty Pharma plc$2.4B5.1%32.4%$39.6BSRPTSarepta Therapeutics, Inc.$2.2B15.6%32.5%$1.7B
PTCTPTC Therapeutics, Inc. (this company)$1.7B114.5%39.4%$5.3B
PAHCPhibro Animal Health Corp$1.5B17.1%6.6%$1.4BALKSAlkermes plc.$1.5B5.2%16.4%$7.9BSUPNSupernus, Inc.$1.2B4.3%16.9%$3.4BNSRXNasus Pharma Ltd$1.2B—0.5%$26.6MPBHPrestige Consumer Healthcare Inc.$1.1B4.3%17.5%$2.1BACADAcadia Pharmaceuticals Inc$1.1B11.9%36.5%$3.7BPeers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in revenue first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.
PTC Therapeutics, Inc. · CIK 1070081 · Engraved from SEC EDGAR